AU2446895A - Use of mao-a inhibitors for the manufacture of a medicament in the treatment of tobacco withdrawal symptoms in smokers - Google Patents

Use of mao-a inhibitors for the manufacture of a medicament in the treatment of tobacco withdrawal symptoms in smokers

Info

Publication number
AU2446895A
AU2446895A AU24468/95A AU2446895A AU2446895A AU 2446895 A AU2446895 A AU 2446895A AU 24468/95 A AU24468/95 A AU 24468/95A AU 2446895 A AU2446895 A AU 2446895A AU 2446895 A AU2446895 A AU 2446895A
Authority
AU
Australia
Prior art keywords
smokers
mao
medicament
inhibitors
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU24468/95A
Inventor
Roman Amrein
Ivan Berlin
Alain Puech
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Assistance Publique Hopitaux de Paris APHP
Original Assignee
F Hoffmann La Roche AG
Assistance Publique Hopitaux de Paris APHP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG, Assistance Publique Hopitaux de Paris APHP filed Critical F Hoffmann La Roche AG
Publication of AU2446895A publication Critical patent/AU2446895A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU24468/95A 1994-04-22 1995-04-20 Use of mao-a inhibitors for the manufacture of a medicament in the treatment of tobacco withdrawal symptoms in smokers Abandoned AU2446895A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH1256/94 1994-04-22
CH125694 1994-04-22
PCT/EP1995/001492 WO1995028934A2 (en) 1994-04-22 1995-04-20 Use of mao-a inhibitors for the manufacture of a medicament in the treatment of tobacco withdrawal symptoms in smokers

Publications (1)

Publication Number Publication Date
AU2446895A true AU2446895A (en) 1995-11-16

Family

ID=4206136

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24468/95A Abandoned AU2446895A (en) 1994-04-22 1995-04-20 Use of mao-a inhibitors for the manufacture of a medicament in the treatment of tobacco withdrawal symptoms in smokers

Country Status (2)

Country Link
AU (1) AU2446895A (en)
WO (1) WO1995028934A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01001180A (en) * 1998-07-31 2002-04-24 Vela Pharmaceuticals Inc Methods and compositions for treating and preventing substance abuse using moclobemide.
FR2788982B1 (en) * 1999-02-02 2002-08-02 Synthelabo PHARMACEUTICAL COMPOSITIONS CONTAINING NICOTINE AND THEIR APPLICATION IN SMOKING WITHDRAWAL
RU2366430C2 (en) 2007-05-23 2009-09-10 Виктор Иванович Рощин Monoaminooxidase inhibitors, therapeutic agent and pharmaceutical composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4999382A (en) * 1988-10-26 1991-03-12 Massachusetts Institute Of Technology Compositions for treating tobacco withdrawal symptoms and methods for their use

Also Published As

Publication number Publication date
WO1995028934A2 (en) 1995-11-02
WO1995028934A3 (en) 1995-11-16

Similar Documents

Publication Publication Date Title
AU2703795A (en) Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
AU4342997A (en) Use of quinazoline derivatives for the manufacture of a medicament in the reatment of hyperproliferative skin disorders
YU37602A (en) A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
HUP0201279A2 (en) Pharmaceutical compositions containing nicotine or a ligand of nicotine receptors and a monamine oxydase inhibitor and their use for treating tobacco withdrawal symptoms
EP0711559A3 (en) Use of phosphatidylserines for the manufacture of a medicament for improving cerebration
AU6528400A (en) Triple drug therapy for the treatment of narcotic and alcohol withdrawal symptoms
IL114128A0 (en) Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms
AU1116895A (en) Use of theophylline for the manufacture of a medicament for the treatment of asthma
IL114129A0 (en) Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms
AU2446895A (en) Use of mao-a inhibitors for the manufacture of a medicament in the treatment of tobacco withdrawal symptoms in smokers
EP0689839A3 (en) Use of inhibitors of adenosine triphosphatase for the manufacture of a medicament for the treatment of disorders anociated with beta-amyloid peptide
IL114130A0 (en) Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms
NO990450L (en) Treatment of mental disorders
AU4179497A (en) Use of PKC inhibitors for the manufacture of a medicament for the treatment f AIDS
CZ223199A3 (en) Use of comt inhibitors or pharmaceutically acceptable salts or esters thereof for preparing a medicament for prevention diabetic vascular dysfunctions
IL114655A (en) USE OF GnRH ANTAGONIST IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF A GONADAL-STEROID DEPENDENT CONDITION IN A MAMMAL
AU3071999A (en) Use of pkc inhibitors for the manufacture of a medicament for the treatment of autoimmune diseases
AU8096094A (en) Use of nicotine substitutes for the treatment of nicotine withdrawal
NO943293L (en) Use of a drug in the treatment of smoking
AU2462097A (en) The use of a substance p antagonist for the manufacture of medicament for the treatment of ocular pain
HUP9801236A3 (en) Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction
AU3071899A (en) Use of pkc-inhibitors for the manufacture of a medicament for the treatment of asthma
AU6702596A (en) Use of pde inhibitors in the manufacture of a medicament for the treatment of bladder diseases
AU2107097A (en) Smoking mixture for use in the treatment of drug dependency
HUP0003908A2 (en) Use of substituted azaspirane in the manufacture of a medicament for use in treating asthma